Direct effects of rosuvastatin on pancreatic human beta cells

Acta Diabetol. 2013 Dec;50(6):983-5. doi: 10.1007/s00592-013-0465-y. Epub 2013 Mar 17.

Authors

Marco Bugliani¹, Farooq Syed, Matilde Masini, Lorella Marselli, Mara Suleiman, Michela Novelli, Franco Filipponi, Ugo Boggi, Pellegrino Masiello, Vincenzo De Tata, Piero Marchetti

Affiliation

¹ Islet Cell Laboratory, Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa, 2, 56124, Pisa, PI, Italy, m.bugliani@ao-pisa.toscana.it.

PMID: 23503985
DOI: 10.1007/s00592-013-0465-y

No abstract available

MeSH terms

Aged
Cells, Cultured
Female
Fluorobenzenes / pharmacology*
Gene Expression Regulation / drug effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Insulin / metabolism
Insulin Secretion
Insulin-Secreting Cells / drug effects*
Insulin-Secreting Cells / metabolism
Insulin-Secreting Cells / ultrastructure
Male
Middle Aged
Pyrimidines / pharmacology*
Rosuvastatin Calcium
Sulfonamides / pharmacology*

Substances

Fluorobenzenes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Insulin
Pyrimidines
Sulfonamides
Rosuvastatin Calcium